Skip to main content
. 2005 Sep;141(3):459–466. doi: 10.1111/j.1365-2249.2005.02875.x

Fig. 5.

Fig. 5

CCL26 mRNA expression in HaCaT cells was determined by RT-PCR when they were stimulated with IL-4, leflunomide, JAK inhibitor 1 and JAK3 inhibitor 1. Leflunomide and JAK inhibitor 1, but not JAK3 inhibitor 1, inhibited IL-4-enhanced CCL26 mRNA expression dose-dependently. When the reverse transcriptase enzyme was omitted, neither CCL26 mRNA nor G3PDH mRNA was detected.